Titration of medical therapy for heart failure with reduced ejection fraction

Greene, Stephen J., Fonarow, Gregg C., DeVore, Adam D., Sharma, Puza P., Vaduganathan, Muthiah, Albert, Nancy M., Duffy, Carol I., Hill, C. Larry +7 more·2019·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2019.02.015

Cited by (499)

Items 101–200 of 499

  1. Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum
    Javed Butler, Muhammad Usman, Kevin Joseph Anstrom, Robert O. Blaustein, Marc P. Bonaca, Justin Adrian Ezekowitz, Cecilia Freitas, Carolyn S.P. Lam, Eldrin Foster Lewis, JoAnn M. Lindenfeld et al. · 2022 · European Journal of Heart Failure
  2. Building a Heart Failure Clinic: A Practical Guide from the Heart Failure Society of America
    Stephen John Greene, Srinath Adusumalli, Nancy M. Albert, Paul J. Hauptman, Michael W. Rich, Paul A. Heidenreich, Javed Butler · 2020 · Journal of Cardiac Failure
  3. The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP‐HF
    Adam D. DeVore, Anne S. Hellkamp, Laine Elliott Thomas, Nancy M. Albert, Javed Butler, James Herbert Patterson, John A. Spertus, Fredonia B. Williams, Xian Shen, Adrian F. Hernandez et al. · 2022 · European Journal of Heart Failure
  4. Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts
    Nicolas Girerd, Christophe Leclercq, Olivier Hanon, Antoni Bayés‐Genís, James L. Januzzi, Thibaut Damy, Benoît Lequeux, Christophe Meune, Pierre François Sabouret, François Roubille · 2023 · Revista Española de Cardiología (English Edition)
  5. Ferric Carboxymaltose for the Treatment of Iron-Deficient Heart Failure Patients: A Systematic Review and Meta-Analysis
    Muhammad Shahzeb Khan, Muhammad Usman, Stephan von Haehling, Wolfram Doehner, Andrew J.S. Coats · 2020 · ESC Heart Failure
  6. The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment
    Monica J. E. Parry, Harriette G.C. Van Spall, Kerri‐Anne Mullen, Sharon L. Mulvagh, Christine Pacheco, Tracey J. F. Colella, Marie-Annick A Clavel, Shahin Jaffer, Heather J.A. Foulds, Jasmine Grewal et al. · 2022 · CJC Open
  7. A Practical Approach to the Guideline-Directed Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction
    Amr Abdin, Johann K Bauersachs, Samira Soltani, Matthias Eden, Norbert Frey, Michael Böhm · 2022 · ESC Heart Failure
  8. Blood pressure in heart failure management and prevention
    Daichi Maeda, Taishi Dotare, Yuya Matsue, KANAKO TERAMOTO, Tsutomu Sunayama, Jasper Tromp, Tohru Minamino · 2023 · Hypertension Research
  9. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation
    Zachary L. Cox, SANDIP K. ZALAWADIYA, Matheus Simonato, Björn Redfors, Zhipeng Zhou, Lak N. Kotinkaduwa, Michael R. Zile, James E. Udelson, David Scott Lim, Paul Arthur Grayburn et al. · 2023 · JACC Heart Failure
  10. Differences in Outcomes between Heart Failure Phenotypes in Patients with Coexistent Chronic Obstructive Pulmonary Disease: A Cohort Study
    Claudia Gulea, Rosita Zakeri, Jennifer Kathleen Quint · 2021 · Annals of the American Thoracic Society
  11. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure.
    Izza Shahid, M. S. Khan, G. Fonarow, J. Butler, S. Greene · 2024 · Progress in cardiovascular diseases
  12. Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013–2021
    Jimmy Gonzalez, Chintan V. Dave · 2024 · BMC Cardiovascular Disorders
  13. Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF
    Adam D. DeVore, Bradi B. Granger, Gregg C. Fonarow, Hussein R. Al‐Khalidi, Nancy M. Albert, Eldrin Foster Lewis, Javed Butler, Ileana L. Piña, Paul A. Heidenreich, Larry A. Allen et al. · 2019 · American Heart Journal
  14. In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial
    Vishal N. Rao, Anand Shah, Jaime McDermott, Stephanie G. Barnes, E. Murray, Michelle D. Kelsey, S. Greene, M. Fudim, A. Devore, C. Patel et al. · 2022 · Circulation: Heart Failure
  15. Implementation of Sacubitril/Valsartan in Sweden: Clinical Characteristics, Titration Patterns, and Determinants
    Michael L.X. Fu, Ola Vedin, Bodil Svennblad, Erik Lampa, Daniel Johansson, Ulf Dahlström, Krister Lindmark, Peter Vaško, Anna Lundberg, Madlaina Costa‐Scharplatz et al. · 2020 · ESC Heart Failure
  16. Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors
    Luca De Nicola, Pietro Manuel Ferraro, Andrea Montagnani, Roberto Pontremoli, Francesco Dentali, Giorgio Sesti · 2023 · Internal and Emergency Medicine
  17. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
    Daniela Tomasoni, Beth A. Davison, Marianna Adamo, Matteo Pagnesi, Alexandre Mebazaa, Christopher Edwards, Mattia Arrigo, Marianela Barros, Jan Biegus, Jelena Čelutkienė et al. · 2023 · Journal of Cardiac Failure
  18. Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
    Stephen John Greene, Su‐Jung Choi, Steven Lippmann, Robert John Mentz, Melissa A. Greiner, Natalie Chantelle Hardy, Bradley G. Hammill, Nancy Luo, Marc D. Samsky, Paul A. Heidenreich et al. · 2021 · Journal of the American Heart Association
  19. Association Between a Hospitalization for Heart Failure and the Initiation/Discontinuation of Guideline-Recommended Treatments: An Analysis from the Swedish Heart Failure Registry
    Benedikt Schrage, Lars H. Lund, Lina Benson, Frieder Braunschweig, João Pedro Ferreira, Ulf Dahlström, Marco Metra, Giuseppe M.C. Rosano, Gianluigi Savarese · 2023 · European Journal of Heart Failure
  20. Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction
    Stanley A. Swat, Haolin Xu, Larry A. Allen, Stephen John Greene, Adam D. DeVore, Roland Matsouaka, Parag Goyal, Pamela N. Peterson, Adrian F. Hernandez, Harlan M. Krumholz et al. · 2023 · JACC Heart Failure
  21. Determinants of Guideline-Directed Medical Therapy Implementation During Heart Failure Hospitalization
    Emily Margolin, Trina Huynh, Alison M. Brann, Barry Greenberg · 2024 · JACC Advances
  22. Nonsteroidal and Steroidal Mineralocorticoid Antagonists
    Josephine Harrington, Mario Enrico Canonico, Abdelghani El Rafei, Scott David Solomon, John R. Teerlink, Muthiah Vaduganathan, Shelley R. Zieroth, Marc P. Bonaca, Andrew J. Sauer · 2025 · JACC Heart Failure
  23. Temporal Trends in Post Myocardial Infarction Heart Failure and Outcomes Among Older Adults
    Ajar Kochar, Jacob Appel Doll, Li Liang, Jerry W. Curran, Eric David Peterson · 2021 · Journal of Cardiac Failure
  24. Management of Heart Failure With Reduced Ejection Fraction
    Ahmed Mustafa Rashid, Muhammad Shahzeb Khan, Marat Fudim, Tracy A. DeWald, Adam D. DeVore, Javed Butler · 2023 · Current Problems in Cardiology
  25. Personalized Care of Patients with Heart Failure: Are we Ready for a REWOLUTION? Insights from two International Surveys on Healthcare Professionals' Needs and Patients' Perceptions
    Ewa Anita Jankowska, Peter P. Liu, Martín Cowie, Max Groenhart, Kelly Denise Cobey, Jonathan G. Howlett, Michel Komajda N, Lars H. Lund, José Antonio Magaña Serrano, Ricardo Mourilhe‐Rocha et al. · 2023 · European Journal of Heart Failure
  26. Residual Risk in Heart Failure and the Need for Simultaneous Implementation and Innovation
    Kaneez Fatima, Javed Butler, Gregg C. Fonarow · 2023 · European Journal of Heart Failure
  27. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures
    Michelle Maya Kittleson, Khadijah K Breathett, Boback Ziaeian, David A. Aguilar, Vanessa L. Blumer, Biykem Bozkurt, Rebecca L. Diekemper, Michael P. Dorsch, Paul A. Heidenreich, Corrine Y. Jurgens et al. · 2024 · Circulation Cardiovascular Quality and Outcomes
  28. Guideline-directed medical therapy in heart failure patients: impact of focused care provided by a heart failure clinic in comparison to general cardiology out-patient department
    Jeeva Joseph, P S Stephy, J James, Suja Abraham, Jabir Abdullakutty · 2020 · The Egyptian Heart Journal
  29. National Trends in the Use of Sacubitril/Valsartan
    Aya Fukuma Ozaki, Harlan M. Krumholz, Freny Vaghaiwalla Mody, Cynthia Anne Jackevicius · 2021 · Journal of Cardiac Failure
  30. Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF)
    Erika M. Giblin, Kirkwood F. Adams, Larry Hill, Gregg C. Fonarow, Fredonia B. Williams, Puza P. Sharma, Nancy M. Albert, Javed Butler, Adam D. DeVore, Carol I. Duffy et al. · 2019 · The American Journal of Cardiology
  31. Pharmacist‐led optimization of heart failure medications: A systematic review
    Vivien Cao, Emily C. Cowley, Sheri L. Koshman, Jenny MacGillivray, Margaret Sidsworth, Ricky D. Turgeon · 2021 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  32. Remote monitoring titration clinic to implement guideline-directed therapy for heart failure patients with reduced ejection fraction: a pilot quality-improvement intervention
    Erick Romero, Stella Yala, Camryn Sellers-Porter, Genevieve Lynch, Veronicah Mwathi, Yvette Hellier, Svetlana Goldman, Paulo Rocha, Jeffrey Fine, David A. Liem et al. · 2023 · Frontiers in Cardiovascular Medicine
  33. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
    Michelle Maya Kittleson, Khadijah K Breathett, Boback Ziaeian, David A. Aguilar, Vanessa L. Blumer, Biykem Bozkurt, Rebecca L. Diekemper, Michael P. Dorsch, Paul A. Heidenreich, Corrine Y. Jurgens et al. · 2024 · Journal of the American College of Cardiology
  34. Treatment Differences in Chronic Heart Failure Patients With Reduced Ejection Fraction According to Blood Pressure
    Jesse F. Veenis, Hans‐Peter Brunner‐La Rocca, Gerard C.M. Linssen, Marco W.F. van Gent, Arno Wilhelmus Hoes, Jasper Jan Brugts, for the CHECK-HF Investigators · 2020 · Circulation Heart Failure
  35. Performance of current risk stratification models for predicting mortality in patients with heart failure: a systematic review and meta-analysis
    Tariq Jamal Siddiqi, Aymen Bushra Ahmed, Stephen John Greene, Izza Shahid, Muhammad Usman, Adebamike A. Oshunbade, Mohamad Adnan Alkhouli, Michael E. Hall, Mohammad Hassan Murad, Rohan Khera et al. · 2022 · European Journal of Preventive Cardiology
  36. Supra-Normal Left Ventricular Function
    Ryohei Ono, Luiz Menezes Falcão · 2023 · The American Journal of Cardiology
  37. Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction
    Marat Fudim, Sabina Sayeed, Haolin Xu, Roland Matsouaka, Paul A. Heidenreich, Eric J. Velazquez, Clyde W. Yancy, Gregg C. Fonarow, Adrian F. Hernandez, Adam D. DeVore · 2020 · Circulation Heart Failure
  38. Advanced Applications of Nanomaterials in Atherosclerosis Diagnosis and Treatment: Challenges and Future Prospects
    Junran Tong, Zhiwen Wang, Jiahui Zhang, Ran Gao, Xiangfei Liu, Yuhan Liao, Xiaopeng Guo, Yumiao Wei · 2024 · ACS Applied Materials & Interfaces
  39. Guideline‐Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT‐HF
    Satoshi Shoji, Lisa A. Kaltenbach, Bradi B. Granger, Gregg C. Fonarow, Hussein R. Al‐Khalidi, Nancy M. Albert, Javed Butler, Larry A. Allen, David E. Lanfear, Jennifer T. Thibodeau et al. · 2024 · Journal of the American Heart Association
  40. Patient Profiles in Heart Failure with Reduced Ejection Fraction: Prevalence, Characteristics, Treatments and Outcomes in a Real-World Heart Failure Population
    Francesca Musella, Giuseppe M.C. Rosano, Camilla Hage, Lina Benson, Federica Guidetti, Brenda Moura, Gerolamo Sibilio, Marco Boccalatte, Ulf Dahlström, Andrew J.S. Coats et al. · 2023 · European Journal of Heart Failure
  41. Device Interventions for Heart Failure
    Husam M. Salah, Marat Fudim, Daniel Burkhoff · 2023 · JACC Heart Failure
  42. Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion
    Guillaume Schurtz, Nathan Mewton, Gilles Lemesle, Clément Delmas, Bruno Lévy, Étienne Puymirat, Nadia Aïssaoui, Fabrice Bauer, Édouard Gerbaud, Patrick Henry et al. · 2023 · Frontiers in Cardiovascular Medicine
  43. Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure
    John Gierula, Judith E. Lowry, Maria F. Paton, Charlotte A. Cole, Rowenna J. Byrom, Aaron O. Koshy, Hemant Chumun, Lorraine C. Kearney, Sam Straw, Thomas Scott Bowen et al. · 2020 · Circulation
  44. A Modern Integration of Palliative Care Into the Management of Heart Failure
    Carrie Puckett, Sarah J. Goodlin · 2020 · Canadian Journal of Cardiology
  45. Sacubitril/valsartan use patterns among older adults with heart failure in clinical practice: a population‐based cohort study of >25 000 Medicare beneficiaries
    Ankeet S. Bhatt, Muthiah Vaduganathan, Scott David Solomon, Sebastian Schneeweiß, Julie C. Lauffenburger, Rishi J. Desai · 2022 · European Journal of Heart Failure
  46. Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure
    Joshua A. Jacobs, Iyanuoluwa Ayodele, Adam Phillip Bress, Madeline R. Sterling, Ambarish Pandey, Catherine G. Derington, Alexander R. Zheutlin, Kevin Shah, Stephen John Greene, Brooke Alhanti et al. · 2024 · Circulation Heart Failure
  47. Sacubitril/Valsartan vs. Angiotensin Receptor Inhibition in Heart Failure: A Real-World Study in Taiwan
    Po‐Cheng Chang, Chun‐Li Wang, Fu‐Chih Hsiao, Ming‐Shien Wen, Chien‐Ying Huang, Chung‐Chuan Chou, Pao‐Hsien Chu · 2020 · ESC Heart Failure
  48. Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry
    Javed Butler, Laurence M. Djatche, Dominik Lautsch, Lingfeng Yang, Mahesh J. Patel, Robert John Mentz · 2021 · Journal of Cardiac Failure
  49. Medical Management of Patients With Heart Failure and Reduced Ejection Fraction
    Barry Greenberg · 2022 · Korean Circulation Journal
  50. Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
    Sam Straw, Charlotte A. Cole, Melanie McGinlay, Michael Drozd, Thomas A Slater, Judith E. Lowry, Maria F. Paton, Eylem Levelt, Richard M. Cubbon, Mark T. Kearney et al. · 2022 · Clinical Research in Cardiology
  51. BLITZ‐HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines
    Michele Massimo Gulizia, Francesco Orso, Andrea Mortara, Donata Lucci, Nadia Aspromonte, Leonardo De Luca, Giuseppe Di Tano, Giuseppe Leonardi, Alessandro Navazio, Giovanni Pulignano et al. · 2022 · European Journal of Heart Failure
  52. Improving implementation of evidence‐based therapies for heart failure
    Adam D. DeVore, Hayden Barry Bosworth, Bradi B. Granger · 2022 · Clinical Cardiology
  53. Heart failure medical therapy prior to mitral transcatheter edge-to-edge repair: the STS/ACC Transcatheter Valve Therapy Registry
    Anubodh Sunny Varshney, Miloni A. Shah, Sreekanth Vemulapalli, Andrzej Stanislaw Kosinski, Ankeet S. Bhatt, Alexander T. Sandhu, Sameer A Hirji, Ersilia M. DeFilippis, Pinak Bipin Shah, Mona Fiuzat et al. · 2023 · European Heart Journal
  54. Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study
    Jiangyue Tian, Mei Dong, Xiaoqian Sun, Xiaoning Jia, Guihua Zhang, Yanling Zhang, Zongwei Lin, Jie Xiao, Xinyu Zhang, Huixia Lu · 2024 · International Journal of Cardiology
  55. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction
    Derek S. Chew, Zak Loring, Jatin Anand, Marat Fudim, Angela M. Lowenstern, Jennifer A. Rymer, Kristin E. D. Weimer, Brett D. Atwater, Adam D. DeVore, Derek V. Exner et al. · 2020 · Circulation Cardiovascular Quality and Outcomes
  56. Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction
    Davide Stolfo, Gianfranco Sinagra, Gianluigi Savarese · 2022 · Cardiac failure review
  57. Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure
    Se-Eun Kim, Dong‐Hyuk Cho, Jung‐Woo Son, Jang‐Young Kim, Seok‐Min Kang, Myeong‐Chan Cho, Hae‐Young Lee, Dong‐Ju Choi, Eun‐Seok Jeon, Byung‐Su Yoo · 2022 · International Journal of Cardiology
  58. Dose Titration of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction: A Real-World Study
    Chen Wang, Zongwei Lin, Dongxia Miao, Hui Zhang, Kang Fu, Xinyu Zhang, Jie Xiao, Yue Hu, Yijun Sun, Fen Wang et al. · 2023 · ESC Heart Failure
  59. Reduction of Heart Failure Guideline-Directed Medication During Hospitalization: Prevalence, Risk Factors, and Outcomes
    Victoria Palin, Michael Drozd, Ellis Garland, Anam Malik, Sam Straw, Melanie McGinlay, Alexander D Simms, V Kate Gatenby, Anshuman Sengupta, Eylem Levelt et al. · 2022 · ESC Heart Failure
  60. The Association of Digital Health Application Use with Heart Failure Care and Outcomes: Insights from CONNECT-HF.
    Vishal N. Rao, L. Kaltenbach, B. Granger, G. Fonarow, H. Al-Khalidi, N. Albert, J. Butler, L. Allen, D. Lanfear, D. Ariely et al. · 2022 · Journal of Cardiac Failure
  61. Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure Phenotypes
    Anique Ducharme, Shelley R. Zieroth, Vineeta Ahooja, Kim Anderson, Jason G. Andrade, Laurie‐Anne Boivin‐Proulx, Justin Adrian Ezekowitz, Jonathan G. Howlett, Serge Lepage, Derek Leong et al. · 2023 · Canadian Journal of Cardiology
  62. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure
    Dennis Grewal, Rod Partow-Navid, Dante Garcia, Joshua Coney, Gary E. Fraser, Liset N. Stoletniy, Antoine Emile Sakr, Purvi J. Parwani, Dmitry Abramov · 2021 · The American Journal of Cardiology
  63. Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis
    Naser Yamani, Aymen Bushra Ahmed, Priyanka Gosain, Kaneez Fatima, Ali Tariq Shaikh, Humera Qamar, Izza Shahid, Muhammad Sameer Arshad, Talal Almas, Vincent M. Figueredo · 2021 · IJC Heart & Vasculature
  64. Building the Foundation for a New Era of Quadruple Therapy in Heart Failure
    Gary Michael Felker · 2019 · Circulation
  65. Quadruple Therapy Is the New Standard of Care for HFrEF
    Tariq Ahmad, Nihar R. Desai · 2020 · JACC Heart Failure
  66. Patient-Reported Outcomes in Patients with Cardiomyopathy
    Raul Angel Garcia, Mary C. Benton, John A. Spertus · 2021 · Current Cardiology Reports
  67. Mineralocorticoid Receptor Antagonist Initiation During Admission is Associated with Improved Outcomes Irrespective of Ejection Fraction in Patients with Acute Heart Failure
    Iris E. Beldhuis, Kevin Damman, Peter S. Pang, Barry Greenberg, Beth A. Davison, Gad Cotter, Claudio R. Gimpelewicz, Gary Michael Felker, Gerasimos S Filippatos, John R. Teerlink et al. · 2023 · European Journal of Heart Failure
  68. Improving Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: A Review of Implementation Strategies
    Josephine Harrington, Vishal N. Rao, Monica Leyva, Megan M. Oakes, Robert John Mentz, Hayden Barry Bosworth, Neha Jadeja Pagidipati · 2023 · Journal of Cardiac Failure
  69. Telehealth for Uptitration of Guideline-Directed Medical Therapy in Heart Failure
    Jennifer T. Thibodeau, Eiran Z. Gorodeski · 2020 · Circulation
  70. Early Initiation of Sodium–Glucose Cotransporter 2 Inhibitors in Acute Heart Failure: A Systematic Review and Meta‐Analysis
    Miloud Cherbi, Olivier Lairez, Guillaume Baudry, Paul Gautier, François Roubille, Clément Delmas · 2025 · Journal of the American Heart Association
  71. Wearable devices and cardiovascular health: revolutionizing remote monitoring and disease prevention
    Andrew M Hughes, Daniel J. Taylor, P D Morris, Evan L. Brittain · 2026 · European Heart Journal
  72. Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients ― A Report From the West Tokyo Heart Failure Registry ―
    Takanori Ohata, Nozomi Niimi, Yasuyuki Shiraishi, Fumiko Nakatsu, Ichiro Umemura, Takashi Kohno, Yuji Nagatomo, Makoto Takei, Tomohiko Ono, Munehisa Sakamoto et al. · 2023 · Circulation Journal
  73. Optimal Medical Therapy and Outcomes Among Patients With Chronic Heart Failure With Reduced Ejection Fraction.
    Vishal N. Rao, A. Hellkamp, Laine E. Thomas, G. Fonarow, M. Fiuzat, C. O'Connor, J. Spertus, A. Desai, N. Albert, Javed Butler et al. · 2024 · JACC. Heart failure
  74. Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction
    Muthiah Vaduganathan, Gregg C. Fonarow, Stephen John Greene, Adam D. DeVore, Nancy M. Albert, Carol I. Duffy, C. Larry Hill, James Herbert Patterson, John A. Spertus, Laine Elliott Thomas et al. · 2021 · Journal of Cardiac Failure
  75. Using Patient-Reported Outcomes to Assess Healthcare Quality: Toward Better Measurement of Patient-Centered Care in Cardiovascular Disease
    Raul Angel Garcia, John A. Spertus · 2021 · Methodist DeBakey Cardiovascular Journal
  76. Impact of SGLT2 Inhibitors on Very Elderly Population with Heart Failure with Reduce Ejection Fraction: Real Life Data
    Jorge Balaguer Germán, Marcelino Cortés, Carlos Rodríguez López, José María Romero Otero, José Antonio Esteban Chapel, Antonio José Bollas Becerra, Luis Nieto Roca, Mikel Taibo Urquía, Ana María Pello Lázaro, José Tuñón · 2024 · Biomedicines
  77. A Guide to Implementation Science for Phase 3 Clinical Trialists
    Harriette G.C. Van Spall, Laura Desveaux, Tracy L Finch, Cara C. Lewis, George A. Mensah, Yves Rosenberg, Kavita Singh, François Venter, Bryan Jeffrey Weiner, Faiez M. Zannad · 2024 · Journal of the American College of Cardiology
  78. Establishing the first pharmacist‐led heart failure medication optimization clinic in the Middle East Gulf Region
    Bassam Atallah, Ziad G. Sadik, Abdisamad A. Osoble, Hussam H. Ghalib, Iman Mukhtar Hamour, Malak AlTakruri, Richard Ferrer, Antoine J. Cherfan, Feras M. Bader · 2020 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  79. Xin-Ji-Er-Kang protects myocardial and renal injury in hypertensive heart failure in mice
    Xin-xin Ling, Hua Chen, Bei-bei Fu, Cheng-shao Ruan, Ming Pana, Kai Zhou, Zhirui Fang, Juntang Shao, Fengqin Zhu, Shan Gao · 2021 · Phytomedicine
  80. Simultaneous or rapid sequence initiation of medical therapies for heart failure: seeking to avoid the case of ‘too little, too late’
    Muhammad Shahzeb Khan, Javed Butler, Stephen John Greene · 2021 · European Journal of Heart Failure
  81. Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines – Heart Failure Registry
    Ankeet S. Bhatt, Gregg C. Fonarow, Stephen John Greene, DaJuanicia N. Holmes, Brooke Alhanti, Adam D. DeVore, Javed Butler, Paul A. Heidenreich, Joanna Huang, Michelle Maya Kittleson et al. · 2023 · Journal of Cardiac Failure
  82. Modifications of Medical Treatment and Outcome After Percutaneous Correction of Secondary Mitral Regurgitation
    Davide Stolfo, Matteo Castrichini, Elena Biagini, Miriam Compagnone, Antonio De Luca, Thomas Caiffa, Alessandra Berardini, Giancarlo Vitrella, Renata Korcova, Andrea Perkan et al. · 2020 · ESC Heart Failure
  83. Racial Differences in Trends and Prognosis of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction: the Atherosclerosis Risk in Communities (ARIC) Surveillance Study
    Lena Mathews, Ning Ding, Yingying Sang, Laura R. Loehr, Jung-Im Shin, Naresh M. Punjabi, Alain G. Bertoni, Deidra C. Crews, Wayne D. Rosamond, Josef Coresh et al. · 2022 · Journal of Racial and Ethnic Health Disparities
  84. Decisional Needs and Patient Treatment Preferences for Heart Failure Medications: A Scoping Review
    Blair J. MacDonald, Arden R. Barry, Ricky D. Turgeon · 2022 · CJC Open
  85. Determinants of maximal dose titration of sacubitril/valsartan in clinical practice
    Pieter Martens, Lina Verluyten, Heleen Van de Broek, Frauke Somers, Jeroen Dauw, Matthias Dupont, Wilfried Müllens · 2019 · Acta cardiologica. Supplementum
  86. The Time Is Now for Sodium Glucose Co-Transporter 2 Inhibitors for Heart Failure
    Muhammad Shahzeb Khan, Javed Butler, Stephen John Greene · 2020 · Circulation Heart Failure
  87. Uptake of Sodium-Glucose Cotransporter-2 Inhibitors in Hospitalized Patients With Heart Failure: Insights From the Veterans Affairs Healthcare System
    Anubodh Sunny Varshney, Jamie Calma, Neil M. Kalwani, Stephanie Hsiao, Karim Sallam, Fang Cao, Natasha Din, Jessica Schirmer, Ankeet S. Bhatt, Andrew P. Ambrosy et al. · 2024 · Journal of Cardiac Failure
  88. Disproportionate secondary mitral regurgitation: myths, misconceptions and clinical implications
    Paul Arthur Grayburn, Milton Packer, Anna Sannino, Gregg W. Stone · 2020 · Heart
  89. Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry
    Uwe Zeymer, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jarosław Dróżdż, Cândida Fonseca, Lars H. Lund, Stefanie Kalus, Philippe C. Ferber, Rizwan Iqbal Hussain et al. · 2021 · European Heart Journal - Quality of Care and Clinical Outcomes
  90. Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes
    Marilyne Jarjour, Jacinthe Leclerc, Nadia Bouabdallaoui, Charaf E Ahnadi, Denis Brouillette, Simon de Denus, Annik Fortier, Patrick Garceau, Geneviève Giraldeau, Serge Lepage et al. · 2022 · International Journal of Cardiology
  91. Impact of a Medication Optimization Clinic on Heart Failure Hospitalizations
    James C. Coons, Jennifer Kliner, Michael A. Mathier, Suresh R Mulukutla, Floyd W. Thoma, Ahmet Sezer, Chad Beisel, Taylor Glassbrenner, Mary Keebler · 2022 · The American Journal of Cardiology
  92. Another reason to embrace quadruple medical therapy for heart failure: medications enabling tolerance of each other
    Stephen John Greene, Javed Butler, Marco Metra · 2021 · European Journal of Heart Failure
  93. Cost-Effectiveness of Earlier Transition to Angiotensin Receptor Neprilysin Inhibitor in Patients With Heart Failure and Reduced Ejection Fraction
    Grant, Andrew D.M., Chew, Derek S., Howlett, Jonathan G., Miller, Robert J.H. · 2020 · CJC Open
  94. Blood Pressure and Intensive Treatment Up-Titration After Acute Heart Failure Hospitalization: Insights from the STRONG-HF Trial
    Matteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, Carlos Alberto Dumont, Alexandre Mebazaa, Beth A. Davison, Marianna Adamo, Mattia Arrigo, Marianela Barros, Jan Biegus et al. · 2024 · European Journal of Heart Failure
  95. Management and outcomes of heart failure hospitalization among older adults in the United States and Japan
    Benjamin A. Bates, N. Enzan, T. Tohyama, Poonam Gandhi, S. Matsushima, H. Tsutsui, Soko Setoguchi, T. Ide · 2024 · ESC Heart Failure
  96. Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HF
    Shingo Matsumoto, Li Shen, Alasdair David Henderson, Michael Böhm, Akshay Suvas Desai, Lars Køber, Martin P. Lefkowitz, Milton Packer, Jean Lucien Rouleau, Scott David Solomon et al. · 2024 · Journal of the American College of Cardiology
  97. Uptitration of Sacubitril/Valsartan and Outcomes in Patients With Heart Failure ― Insight From the REVIEW-HF Registry ―
    Shunichi Doi, Keisuke Kida, Takahito Nasu, Shunsuke Ishii, Nobuyuki Kagiyama, Wataru Fujimoto, Atsushi Kikuchi, Takeshi Ijichi, Tatsuhiro Shibata, Koshiro Kanaoka et al. · 2024 · Circulation Journal
  98. Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial
    Jacob B. Pierce, Robert John Mentz, Jie‐Lena Sun, Brooke Alhanti, David J. Whellan, William E. Kraus, Ileana L. Piña, Mona Fiuzat, Christopher M. O’Connor, Stephen John Greene · 2022 · American Heart Journal
  99. Advances in the Management of Acute Decompensated Heart Failure
    Sumeet Singh Mitter, Sean Pinney · 2020 · Medical Clinics of North America
  100. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities
    Nancy M. Albert, Rachel Tyson, C. Larry Hill, Adam D. DeVore, John A. Spertus, Carol I. Duffy, Javed Butler, James Herbert Patterson, Adrian F. Hernandez, Fredonia B. Williams et al. · 2021 · American Heart Journal